Last reviewed · How we verify

NCT03820245

Effect of Short-term Annatto Carotenoids Supplementation on Oxidative Stress Status in Healthy Individuals

Completed NA Last updated 2 January 2020
What this trial tests

NA trial testing Bixin in Oxidative Stress in 16 participants. Completed in 25 July 2018.

Timeline
24 August 2016
Primary endpoint
15 April 2018
25 July 2018

Quick facts

Lead sponsorUniversidade Federal de Santa Maria
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeprevention
Enrollment16
Start date24 August 2016
Primary completion15 April 2018
Estimated completion25 July 2018
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Federal de Santa Maria — full company profile →

Who can join

Adults 18 to 35, any sex, with Oxidative Stress or Atherosclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low-density lipoprotein (LDL) oxidation has a pivotal role in atherosclerosis development. There is a relationship between carotenoids serum concentration and cardiovascular (CV) benefits, mainly in oxidized LDL (oxLDL) reduction. Despite cardio protective effects of annatto carotenoids, bixin and norbixin, in vitro and in animal studies, its short or long-term supplementation effect on humans are not know. Objective: To analyse CV benefits of annatto carotenoids short-term supplementation in healthy individuals, comparing to lycopene effect. Methods: 16 healthy volunteers (8 men and 8 women) consumed 0.05 mg/kg b.w. of each treatment (bixin, norbixin, lycopene or placebo) through capsules, during 7 days. It was analysed the susceptibility of LDL to Cu2+-induced oxidation, biochemical parameters and oxidative stress biomarkers at the beginning and end of each treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Anti-oxidative stress treatment and current clinical trials.
    Zhang CY, Yang M. · · 2024 · cited 3× · PMID 38495278 · DOI 10.4254/wjh.v16.i2.294

Verify or expand the search:

Other recruiting trials for Oxidative Stress

Currently open trials in the same condition.

Other Universidade Federal de Santa Maria trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03820245.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing